Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco M E Vogel

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
JMIR Mhealth and Uhealth|January 11, 2021
Web-Based Patient Self-Reported Outcome After Radiotherapy in Adolescents and Young Adults With Cancer: Survey on Acceptance of Digital ToolsMarco M E Vogel, Kerstin A Eitz, Stephanie E Combs
Frontiers in Oncology|March 29, 2017
mHealth and Application Technology Supporting Clinical Trials: Today's Limitations and Future Perspective of smartRCTsMarco M E Vogel, Stephanie E Combs, Kerstin A Kessel
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 23, 2022
Coronavirus disease 2019 and radiation oncology-survey on the impact of the severe acute respiratory syndrome coronavirus 2 pandemic on health care professionals in radiation oncologyMarco M E Vogel, Carmen Kessel, Kerstin A Eitz, et al.
Endocrine Pathology|April 15, 2026
Thyroblastoma Dominated by a Primitive Small Round Cell Component: A Diagnostic PitfallAtsuko Kasajima, Marco M E Vogel, Günter Klöppel, et al.
Cancers|December 23, 2023
SBRT of Spinal Metastases Using a Simultaneous Integrated Boost Concept in Oligometastatic Cancer Patients Is Safe and EffectiveMaria Waltenberger, Christian Strick, Marco M E Vogel, et al.
Journal of Medical Internet Research|November 26, 2016
Mobile Apps in Oncology: A Survey on Health Care Professionals' Attitude Toward Telemedicine, mHealth, and Oncological AppsKerstin A Kessel, Marco M E Vogel, Friederike Schmidt-Graf, et al.
BMC Cancer|July 7, 2021
Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survivalTheresa Voglhuber, Kerstin A Eitz, Markus Oechsner, et al.
BMC Cancer|June 10, 2020
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastasesTheresa Voglhuber, Kerstin A Kessel, Markus Oechsner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 6, 2018
Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomyMarco M E Vogel, Kerstin A Kessel, Jürgen E Gschwend, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 3, 2016
Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaireKerstin A Kessel, Hanna Fischer, Marco M E Vogel, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
JMIR Mhealth and Uhealth|January 11, 2021
Web-Based Patient Self-Reported Outcome After Radiotherapy in Adolescents and Young Adults With Cancer: Survey on Acceptance of Digital ToolsMarco M E Vogel, Kerstin A Eitz, Stephanie E Combs
Frontiers in Oncology|March 29, 2017
mHealth and Application Technology Supporting Clinical Trials: Today's Limitations and Future Perspective of smartRCTsMarco M E Vogel, Stephanie E Combs, Kerstin A Kessel
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 23, 2022
Coronavirus disease 2019 and radiation oncology-survey on the impact of the severe acute respiratory syndrome coronavirus 2 pandemic on health care professionals in radiation oncologyMarco M E Vogel, Carmen Kessel, Kerstin A Eitz, et al.
Endocrine Pathology|April 15, 2026
Thyroblastoma Dominated by a Primitive Small Round Cell Component: A Diagnostic PitfallAtsuko Kasajima, Marco M E Vogel, Günter Klöppel, et al.
Cancers|December 23, 2023
SBRT of Spinal Metastases Using a Simultaneous Integrated Boost Concept in Oligometastatic Cancer Patients Is Safe and EffectiveMaria Waltenberger, Christian Strick, Marco M E Vogel, et al.
Journal of Medical Internet Research|November 26, 2016
Mobile Apps in Oncology: A Survey on Health Care Professionals' Attitude Toward Telemedicine, mHealth, and Oncological AppsKerstin A Kessel, Marco M E Vogel, Friederike Schmidt-Graf, et al.
BMC Cancer|July 7, 2021
Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survivalTheresa Voglhuber, Kerstin A Eitz, Markus Oechsner, et al.
BMC Cancer|June 10, 2020
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastasesTheresa Voglhuber, Kerstin A Kessel, Markus Oechsner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 6, 2018
Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomyMarco M E Vogel, Kerstin A Kessel, Jürgen E Gschwend, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 3, 2016
Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaireKerstin A Kessel, Hanna Fischer, Marco M E Vogel, et al.
Pageof 4